Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

IHS Inc. Reaffirms 2012 Outlook - Quick Facts

RELATED NEWS
Trade IHS now with 

IHS Inc. (IHS: Quote) backed its 2012 revenue, adjusted EBITDA and adjusted earnings per share guidance.

The company continues to expect adjusted earnings per share between $3.84 and $4.01, on all-in revenue in a range of $1.53 billion to $1.58 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $3.97 per share, on revenues of $1.55 billion. Analysts' estimates typically exclude special items.

All-in Adjusted EBITDA is still anticipated to be in a range of $488 million to $504 million.

Click here to receive FREE breaking news email alerts for IHS INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A number of major retailers will be open on Thanksgiving for early Black Friday shopping events. Kohl's department stores will kick off Black Friday sales two hours earlier this year, at 6 p.m. Thanksgiving Day, while Macy's, Bon-Ton and Best Buy will open at the same time. J.C. Penney and Sears... Twitter Inc. has replaced its head of product Daniel Graf just six months after luring him over from Google, according to multiple reports. Graf, previously known for his work leading Google Maps, will retain his vice president of product title and work on Twitter's geolocation features, the Wall... LinkedIn Corp., the world's largest online professional network, said Thursday after the markets closed that its third quarter loss widened slightly from last year, as higher costs and expenses more than offset a 45% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.